Table 3.
Partial Univariate Cox Regression Analysis for Predictors of HF in ACS Patients Following PCI Over a 2-Year Follow-Up
| Variables | HR | 95% CI | P value |
|---|---|---|---|
| Age | 1.048 | 1.017, 1.080 | 0.002 |
| Male sex | 2.376 | 1.269, 4.448 | 0.007 |
| BMI | 0.995 | 0.902, 1.097 | 0.915 |
| Hypertension | 1.331 | 0.717, 2.473 | 0.365 |
| DM | 0.964 | 0.444, 2.093 | 0.926 |
| Family history | 0.636 | 0.332, 1.221 | 0.174 |
| Past MI | 1.499 | 0.715, 3.143 | 0.284 |
| Past PCI or CABG | 1.434 | 0.701, 2.934 | 0.324 |
| LVEF | 0.994 | 0.970, 1.020 | 0.657 |
| Hemoglobin | 1.006 | 0.988, 1.025 | 0.538 |
| RBC count | 0.998 | 0.989, 1.007 | 0.636 |
| MCV | 0.929 | 0.886, 0.975 | 0.003 |
| MCH | 0.853 | 0.746, 0.976 | 0.020 |
| MCHC | 1.006 | 0.981, 1.031 | 0.642 |
| PLT count | 1.005 | 1.001, 1.010 | 0.023 |
| WBC count | 0.999 | 0.997, 1.002 | 0.806 |
| NEUT count | 1.086 | 0.962, 1.225 | 0.183 |
| LYMPH count | 1.801 | 1.270, 2.554 | 0.001 |
| MONO count | 1.108 | 0.305, 4.028 | 0.876 |
| EO count | 9.935 | 2.136, 46.215 | 0.003 |
| EO % | 1.164 | 1.008, 1.344 | 0.039 |
| NEUT % | 0.988 | 0.957, 1.020 | 0.453 |
| LYMPH % | 1.017 | 0.983, 1.053 | 0.329 |
| MONO % | 0.915 | 0.819, 1.022 | 0.114 |
| CKMB | 0.996 | 0.989, 1.002 | 0.199 |
| NT-proBNP | 1.000 | 0.999, 1.000 | 0.157 |
| LDL-C | 0.785 | 0.531, 1.162 | 0.226 |
| Blood glucose | 0.834 | 0.671, 1.036 | 0.101 |
| D-Dimer | 0.918 | 0.589, 1.431 | 0.706 |
| Fibrinogen | 0.901 | 0.653, 1.242 | 0.523 |
Note: Bold font denotes P < 0.05.
Abbreviations: HF, heart failure; ACS, acute coronary syndromes; PCI, percutaneous coronary intervention; HR, hazard ratio; CI, confidence interval; BMI, body mass index; DM, Diabetes Mellitus; MI, myocardial infarction; CABG, coronary artery bypass grafting; LVEF, left ventricular ejection fraction; RBC, red blood cell; MCH, mean corpuscular hemoglobin; MCHC, mean corpuscular hemoglobin concentration; MCV, mean corpuscular volume; PLT, Platelet; WBC, white blood cell; NEUT, Neutrophilic granulocyte; LYMPH, Lymphocyte; MONO, Monocyte; EO, Eosinophilic granulocyte; LDL-C, low-density lipoprotein cholesterol; NT-proBNP, N-terminal pro-B-type natriuretic peptide; CKMB, creatine kinase isoenzymes MB.